SD

Sumeet Dhiman

Director Director DIN 07625496
DIN 07625496 First appointment Sep 2016 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Sep 2016
Shareholding value •••• Premium profile

About Sumeet Dhiman

Data last updated:

Sumeet Dhiman was a Director at Mprs Biological Private Limited (2016–2017) and Director at Low Price Medicine.Com Private Limited (2017–2020). The companies operate in Healthcare.

DIN 07625496
Primary Designation Director
Industry Healthcare
First Appointment 28 Sep 2016

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mprs Biological Private Limited U33110DL2014PTC267306
Director28 Sep 20162014₹5.32 Cr (FY 2025)Active
Director21 Mar 20172017Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Mprs Biological Private Limited
Low Price Medicine.Com Private Limited
Premium access

Shareholding and investment profile for Sumeet Dhiman

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sumeet Dhiman

Sumeet Dhiman was first appointed on 28 Sep 2016 as Director at Mprs Biological Private Limited. The most recent appointment on record is 21 Mar 2017 at Low Price Medicine.Com Private Limited.

Sumeet Dhiman held 2 earlier board appointments: Mprs Biological Private Limited (Director, 28 Sep 2016 to 08 Sep 2017); Low Price Medicine.Com Private Limited (Director, 21 Mar 2017 to 20 Feb 2020).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available